To close or not to close: contemporary indications for patent foramen ovale closure

References

• Moore KL. The developing human. Clinically oriented embryology. 6th ed. Philadelphia (PA): Saunders; 1998.
   Google Scholar
• Clark EB. Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol. 1996;20:465–472.
   PubMed Web of Science ®Google Scholar
• Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17–20.
   PubMed Web of Science ®Google Scholar
• Steiner MM, Di Tullio MR, Rundek T, et al. Sacco RL Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke. 1998 May;29(5):944–948.
   PubMed Web of Science ®Google Scholar
• Jung JM, Lee JY, Kim HJ, et al. Patent foramen ovale and infarct volume in cryptogenic stroke. J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1399–1404.
   PubMed Web of Science ®Google Scholar
• Homma S, Di Tullio MR, Sacco RL, et al. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke. 1994 Mar;25(3):582–586.
   PubMed Web of Science ®Google Scholar
• Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148–1152.
   PubMed Web of Science ®Google Scholar
• Hickie JB. The valve of the inferior vena cava. Br Heart J. 1956;18:320–326.
   PubMedGoogle Scholar
• Morishita Y, Yamashita M, Yamada K, et al. Cyanosis in atrial septal defect due to persistent eustachian valve. Ann Thorac Surg. 1985;40(6):614–616.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38–e360.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.
   PubMed Web of Science ®Google Scholar
• Li L, Yiin GS, Geraghty OC, et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol. 2015;14:903–913.
   PubMed Web of Science ®Google Scholar
• Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009;40:551–554.
   PubMed Web of Science ®Google Scholar
• Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989;25:382–390.
   PubMed Web of Science ®Google Scholar
• Handke M, Harloff A, Olschewski M, et al. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357:2262–2268.
   PubMed Web of Science ®Google Scholar
• Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55:1172–1179.
   PubMed Web of Science ®Google Scholar
• Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am. Heart J. 1995 Nov 30;130(5):1083–1088.
   PubMed Web of Science ®Google Scholar
• Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992 Dec;86(6):1902–1908.
   PubMed Web of Science ®Google Scholar
• Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366:991–999.
   PubMed Web of Science ®Google Scholar
• Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368:1083–1091.
   PubMed Web of Science ®Google Scholar
• Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368:1092–1100.
   PubMed Web of Science ®Google Scholar
• Messé SR, Silverman IE, Kizer JR, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004 Apr 13;62(7):1042–1050.
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest J. 2012 Feb 1;141(2):e419S-e496S.
   PubMed Web of Science ®Google Scholar
• Kernan, WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul;45(7):2160–2236.
   PubMed Web of Science ®Google Scholar
• Sherman JM, Hagler DJ, Cetta F. Thrombosis after septal closure device placement: a review of the current literature. Catheter Cardiovasc Interv. 2004 Dec 1;63(4):486–489.
   PubMed Web of Science ®Google Scholar
• Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004;43(2):302–309.
   PubMed Web of Science ®Google Scholar
• Hornung M, Bertog SC, Franke J, et al. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale. Eur Heart J. 2013;34(43):3362–3369. .
   PubMed Web of Science ®Google Scholar
• Stortecky S, Da Costa BR, Mattle HP, et al. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J. 2014 Aug 11:ehu292.
   Google Scholar
• Thaler DE, Ruthazer R, Weimar C, et al. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs. Neurology. 2014;83:221–226.
   PubMed Web of Science ®Google Scholar
• Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81:619–625.
   PubMed Web of Science ®Google Scholar
• Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363:1491–1502.
   PubMed Web of Science ®Google Scholar
• Halliday A, Harrison M, Hayter E, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376:1074–1084.
   PubMed Web of Science ®Google Scholar
• RESPECT confirms long-term safety, efficacy of PFO closure for recurrent stroke. San Francisco (CA): Transcatheter Therapeutic Conference; 2015. Available from: http://www.tctmd.com/show.aspx?id=132727
   Google Scholar
• Pineda AM, Nascimento FO, Yang SC, et al. A meta‐analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events. Catheter Cardiovasc Interv. 2013 Nov 15;82(6):968–975.
   PubMed Web of Science ®Google Scholar
• Khan AR, Abdulhak AA, Sheikh MA, et al. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2013 Dec 1;6(12):1316–1323.
   PubMed Web of Science ®Google Scholar
• Rengifo-Moreno P, Palacios IF, Junpaparp P, et al. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J. 2013 Jul 11:eht285.
   Google Scholar
• Ntaios G, Papavasileiou V, Makaritsis K, et al. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Int J Cardiol. 2013 Oct 30;169(2):101–105.
   PubMed Web of Science ®Google Scholar
• Kwong JS, Lam YY, Yu CM. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials. Int J Cardiol. 2013 Oct 9;168(4):4132–4138.
   PubMed Web of Science ®Google Scholar
• Udell JA, Opotowsky AR, Khairy P, et al. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses. Can J Cardiol. 2014 Oct 31;30(10):1216–1224.
   PubMed Web of Science ®Google Scholar
• Li J, Liu J, Liu M, et al. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack. Cochrane Database Syst Rev. 2015 Sep 8.
   Web of Science ®Google Scholar
• Kent DM, Dahabreh IJ, Ruthazer R, et al. Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J Am Coll Cardiol. 2016 Mar 1;67(8):907–917.
   PubMed Web of Science ®Google Scholar
• Bove AA. Risk of decompression sickness with patent foramen ovale. Undersea Hyperb Med. 1998;25:175.
   PubMed Web of Science ®Google Scholar
• Torti SR, Billinger M, Schwerzmann M, et al. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J. 2004;25:1014–1020.
   PubMed Web of Science ®Google Scholar
• Bové AA, Moon RE Patent foramen ovale - is it important to divers? Available from: http://www.diversalertnetwork.org/medical/articles/Patent_Foramen_Ovale_Is_It_Important_to_Divers
   Google Scholar
• Billinger M, Zbinden R, Mordasini R, et al. Patent foramen ovale closure in recreational divers: effect on decompression illness and ischaemic brain lesions during long-term follow-up. Heart. 2011 Dec;97(23):1932–1937.
   PubMed Web of Science ®Google Scholar
• Honěk J, Srámek M, Sefc L, et al. Effect of catheter-based patent foramen ovale closure on the occurrence of arterial bubbles in scuba divers. JACC Cardiovasc Interv. 2014;7(4):403–408.
   PubMed Web of Science ®Google Scholar
• Smart D, Mitchell S, Wilmshurst P, et al. Joint position statement on persistent foramen ovale (PFO) and diving. South Pacific Underwater Medicine Society (SPUMS) and the United Kingdom Sports Diving Medical Committee (UKSDMC). Diving Hyperb Med. 2015 Jun;45(2):129–131.
   PubMed Web of Science ®Google Scholar
• Cheng TO. Mechanisms of platypnea-orthodeoxia: what causes water to flow uphill? Circulation. 2002;105:e47.
   PubMed Web of Science ®Google Scholar
• Cheng TO. Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interv. 1999;47:64–66.
   PubMed Web of Science ®Google Scholar
• Guérin P, Lambert V, Godart F, et al. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: results of a multicentric French registry. Cardiovasc Intervent Radiol. 2005;28:164–168.
   PubMed Web of Science ®Google Scholar
• Mojadidi MK, Gevorgyan R, Noureddin N, et al. The effect of patent foramen ovale closure in patients with platypnea‐orthodeoxia syndrome. Catheter Cardiovasc Interv. 2015;86(4):701–707.
   PubMed Web of Science ®Google Scholar
• Loud PA, Katz DS, Bruce DA, et al. Deep venous thrombosis with suspected pulmonary embolism: detection with combined CT venography and pulmonary angiography. Radiology. 2001;219:498–502.
   PubMed Web of Science ®Google Scholar
• Stollberger C. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med. 1993;119:461–465.
   PubMed Web of Science ®Google Scholar
• Ranoux D, Cohen A, Cabanes L, et al. Patent foramen ovale: is stroke due to paradoxical embolism? Stroke. 1993;24:31–34.
   PubMed Web of Science ®Google Scholar
• Botto N, Spadoni I, Giusti S, et al. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke. 2007;38(7):2070–2073.
   PubMed Web of Science ®Google Scholar
• Henry P, Auray JP, Gaudin AF, et al. Prevalence and clinical characteristics of migraine in France. Neurology. 2002;59:232–237.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:103–104.
   PubMed Web of Science ®Google Scholar
• Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356:1648–1651.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia. 2008;28:531–540.
   PubMed Web of Science ®Google Scholar
• Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005;45:493–495.
   PubMed Web of Science ®Google Scholar
• Kato Y, Kobayashi T, Ishido H, et al. Migraine attacks after transcatheter closure of atrial septal defect. Cephalalgia. 2013;33:1229–1237.
   PubMed Web of Science ®Google Scholar
• Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117:199–210.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Dodick DW. Patent foramen ovale and migraine – bringing closure to the subject. Headache J Head Face Pain. 2006;46:663–671.
   PubMed Web of Science ®Google Scholar
• Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397.
   PubMed Web of Science ®Google Scholar
• Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J. 2016 Feb 23:ehw027.
   Google Scholar
• Tobis J, Charles A, Silberstein SD, et al. TCT-30 PREMIUM Trial: Double blind study of percutaneous closure of patent foramen ovale with the AMPLATZER® PFO Occluder as a treatment for migraine with or without aura. J Am Coll Cardiol. 2015;66(15):B13. doi:10.1016/j.jacc.2015.08.076.
   Web of Science ®Google Scholar
• Goel SS, Tuzcu EM, Shishehbor MH, et al. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol. 2009 Jan 1;103(1):124–129.
   PubMed Web of Science ®Google Scholar
• Agmon Y, Khandheria BK, Meissner I, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation. 1999;99(15):1942.
   PubMed Web of Science ®Google Scholar
• Mattioli AV, Aquilina M, Oldani A, et al. Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid arteries. A multicentre study. Eur Heart J. 2001;22:261–268.
   PubMed Web of Science ®Google Scholar